56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)
3èmes journées françaises de Neurochirurgie (SFNC)
Deutsche Gesellschaft für Neurochirurgie e. V.
Société Française de Neurochirurgie
07. bis 11.05.2005, Strasbourg
Lectures 10.05.
10.05.-09 Glioma 4
Meeting Abstract
(10.05.-09.01)
[Volltext]
Prognostic value of amino-acid PET with FET in 85 patients with newly diagnosed glioma-suspicious intracerebral lesions
Floeth F, Reifenberger G, Langen KJ, Pauleit D, Steiger HJ, Sabel M[Volltext]
Meeting Abstract
(10.05.-09.02)
[Volltext]
MGMT methylation as a potential outcome predictor in patients with malignant gliomas treated with adjuvant temozolomide chemotherapy
Luyken C, Loeser S, Willers R, Steiger H, Reifenberger G, Sabel M[Volltext]
Meeting Abstract
(10.05.-09.03)
[Volltext]
Investigation of interaction between neuroepithelial brain tumours and surrounding brain parenchyma based on neural cell adhesion molecule
Kuhn SA, Ebmeier K, Brodhun M, Reichart R, Katenkamp D, Kalff R[Volltext]
Meeting Abstract
(10.05.-09.04)
[Volltext]
High predictive value of hemizygous deletions at the Notch2 locus for survival of primary brain tumour patients
Zweifel C, Boulay JL, Miserez AR, Ghaffari A, Reifenberger G, Merlo A[Volltext]
Meeting Abstract
(10.05.-09.05)
[Volltext]
Inhibition of intracerebral glioblastoma growth by treatment with a novel one-armed anti-MET antibody
Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Schwall R, Westphal M, Lamszus K[Volltext]
Meeting Abstract
(10.05.-09.06)
[Volltext]
Gene therapy for high-grade glioma with an adenoviral vector containing the Herpes Simplex virus thymidine kinase gene (Cerepro™)
Sandmair AM, Vapalahti M, Immonen A, Tynnela K, Hurskainen H, Vanninen R, Langford G, Murray N, Ylä-Herttuala HS[Volltext]
